NCT07495631
- Conditions
- Acute Lymphoblastic Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Hemic and Lymphatic Diseases
Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
21,109 public trials
4,000 recruiting studies
Hemic and Lymphatic Diseases trial results
NCT05389293
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Georgetown University (Data Collection Only) Washington D.C., District of Columbia, United States
- Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities Basking Ridge, New Jersey, United States
- Hackensack Meridian Health (Data collection only) Hackensack, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
NCT05887167
- Conditions
- Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +28 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
Recruiting
Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
NCT05108519
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06390319
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
- Locations
-
- Rady Children's Hospital San Diego, California, United States
- Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States
- Saint Francis Children's Hospital Tulsa, Oklahoma, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Recruiting
Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma.
NCT07739654
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Mayo Hospital Lahore, Punjab Province, Pakistan
NCT07756034
- Conditions
- Cancer, Hematologic Diseases, Hematologic Malignancies, +6 more
- Locations
-
- Tempus AI Chicago, Illinois, United States
NCT06542250
- Conditions
- B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site Rochester, Minnesota, United States
- Research Site Hackensack, New Jersey, United States
NCT07409454
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China
Recruiting
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
NCT03618550
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- City of Hope Cancer Center (Data Collection Only) Duarte, California, United States
- Stanford University Medical Center Stanford, California, United States
- University of Miami Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States